Method and apparatus for the guided ablative therapy of fast ventricular arrhythmia by Barley, Maya & Cohen, Richard J.
mu uuuu ui iiui iiui mu mu uui uiii iuu lull uuii uu uii mi
(12) United States Patent
Cohen et al.
(54) METHOD AND APPARATUS FOR THE
GUIDED ABLATIVE THERAPY OF FAST
VENTRICULAR ARRHYTHMIA
(75) Inventors: Richard J. Cohen, Chestnut Hill, MA
(US); Maya Barley, Somerville, MA
(US)
(73) Assignee: Massachusetts Institute of Technology,
Cambridge, MA (US)
(*) Notice: Subject to any disclaimer, the term of this
patent is extended or adjusted under 35
U.S.C. 154(b) by 1088 days.
(21) Appl. No.: 11/376,994
(22) Filed:	 Mar. 16, 2006
(65)	 Prior Publication Data
US 2007/0219452 Al	 Sep. 20, 2007
(51) Int. Cl.
A 61 5104	 (2006.01)
(52) U.S. Cl . ......................... 600/373; 600/515; 606/45;
606/46
(58) Field of Classification Search ............. 606/32-34,
606/507-508; 600/515-516, 373, 509, 518,
600/544, 101
See application file for complete search history.
(56)	 References Cited
U.S. PATENT DOCUMENTS
(1o) Patent No.:	 US 7,792,563 B2
(45) Date of Patent:	 Sep. 7, 2010
5,311,873 A 5/1994 Savard et al.
6,308,094 B1 10/2001 Shusterman et al.
6,370,412 B1 4/2002 Armoundas et al.
2002/0123747 Al* 9/2002 Wentzel et al ................. 606/41
2004/0059237 Al* 3/2004 Narayan et al . 	 ............. 600/509
2006/0270915 Al* 11/2006 Ritter et al .	 ................. 600/300
2007/0060829 Al* 3/2007 Pappone	 ..................... 600/509
OTHER PUBLICATIONS
International Search Report of the International Searching Authority
for International Application No. PCT/US07/06620 mailed Feb. 20,
2008.
Written Opinion of the International Searching Authority for Inter-
national Application No. PCT/US07/06620 mailed Feb. 20, 2008.
* cited by examiner
Primary Examiner Linda C Dvorak
Assistant Examiner 7aymi Della
(57)	 ABSTRACT
Method and apparatus for guiding ablative therapy of abnor-
mal biological electrical excitation. The excitation from the
previous excitatory wave is significant at the beginning of the
next excitation. In particular, it is designed for treatment of
fast cardiac arrhythmias. Electrical signals are acquired from
recording electrodes, and an inverse dipole method is used to
identify the site of origin of an arrhythmia. The location of the
tip of an ablation catheter is similarly localized from signals
acquired from the recording electrodes while electrical pac-
ing energy is delivered to the tip of the catheter close to or in
contact with the cardiac tissue. The catheter tip is then guided
to the site of origin of the arrhythmia, and ablative radio
frequency energy is delivered to its tip to ablate the site.
5,172,690 A * 12/1992 Nappholz et al . ............. 607/13	 16 Claims, 2 Drawing Sheets
Applying a multiplicity of recording electrodes to the body.
Initiating the arrhythmia by means of electrical stimulation of the heart.
Analyzing the electrical activity at a multiplicity of time epochsduring the
cardiac cycle, possibly involving computing the location of at least one
Determining the location of the site of origin of the arrhythmia by applying a
set of criteria to the analyses of electrical activity.
Viewing the location of the site of origin of the arrhythmia on a graphical user
interface.
Introducing one or more stimulating electrodes into the body.
Delivering supra-threshold electrical energy to the
heart through at least one stimulating electrode.
Acquiring from the recording electrodes the signals
emanating from the at least one stimulating electrode
and the activated cardiac tissue.
Identifying the locations of the one or more
stimulating electrodes by analyzing the electrical 	 Iterate
activity at a multiplicity of time epochs during the
cardiac cycle.
Displaying the relative locations of the at least one
stimulating electrode on a graphical user interface.
Positioning the at least one stimulating electrode to
localize the site of origin of the arrhythmia.
Delivering radio frequency ablative energy to the site
of origin of the arrhythmia.
https://ntrs.nasa.gov/search.jsp?R=20100040626 2019-08-30T13:34:53+00:00Z
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Applying a multiplicity of recording electrodes to the body.
Initiating the arrhythmia by means of electrical stimulation of the heart.
Analyzing the electrical activity at a multiplicity of time epochs during the
cardiac cycle, possibly involving computing the location of at least one
equivalent moving dipole.
Determining the location of the site of origin of the arrhythmia by applying a
set of criteria to the analyses of electrical activity.
Viewing the location of the site of origin of the arrhythmia on a graphical user
interface.
Introducing one or more stimulating electrodes into the body.
Delivering supra-threshold electrical energy to the
heart through at least one stimulating electrode.
Acquiring from the recording electrodes the signals
emanating from the at least one stimulating electrode
and the activated cardiac tissue.
Identifying the locations of the one or more
stimulating electrodes by analyzing the electrical
	 Iterate
activity at a multiplicity of time epochs during the
cardiac cycle.
Displaying the relative locations of the at least one
stimulating electrode on a graphical user interface.
Positioning the at least one stimulating electrode to
localize the site of origin of the arrhythmia.
Delivering radio-frequency ablative energy to the site
of origin of the arrhythmia.
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METHOD AND APPARATUS FOR THE 	 several days to several weeks after an apparently successful
GUIDED ABLATIVE THERAPY OF FAST	 ablation [Langberg, 1992]. Conversely, an arrhythmia site of
VENTRICULAR ARRHYTHMIA
	
	
origin that was not initially successfully ablated may later
become permanently nonfunctional if it lies within the border
GOVERNMENT SUPPORT
	
	
5 zone of a lesion and if microvascular injury and inflammation
within this zone result in progressive necrosis [Math, 1994].
This invention was made with government support under	 Thus, the efficacy and long term outcome of catheter ablation
Grant Number NCC958-3, awarded by NASA. The govern- 	 depend on accurate determination of the site of origin of the
ment has certain rights in the invention. 	 arrhythmia.
io	 Catheter ablation of sustained monomorphic ventricular
BACKGROUND OF THE INVENTION
	
	
tachycardia late after myocardial infarction has been chal-
lenging. These arrhythmias arise from reentry circuits that
This invention relates to method and apparatus for guided 	 can be large and complex, with broad paths and narrow isth-
ablative therapy and more particularly to such therapy to treat 	 muses, and that may traverse subendocardial, intramural, and
fast ventricular arrhythmia.	 15 epicardial regions of the myocardium [deBakker, 1991; Kalt-
The electrical activity generated in certain organs in the 	 enbrunner, 1991]. Mapping and ablation are further compli-
human body is intimately related to the organs' functions. 	 cated by the frequent presence of multiple reentry circuits,
Abnormalities in cardiac and brain electrical conduction pro- 	 giving rise to several morphologically different ventricular
cesses are principal causes of morbidity and mortality in the	 tachycardiac [Wilbur, 1987; Waspel, 1985]. In some cases,
developed world. Appropriate treatment of disorders arising 20 different reentry circuits form in the same abnormal region. In
from such abnormalities frequently requires a determination	 other cases, reentry circuits form at disparate sites in the
of their location. Such localization of the site of origin of an 	 infarct area. The presence of multiple morphologies of induc-
abnormal electrical excitation is typically achieved by pains- 	 ible or spontaneous ventricular tachycardia has been associ-
taking mapping of the electrical activity on the inner surface 	 ated with antiarrhythmic drug inefficacy [Mitrani, 1993] and
of the heart or the brain from electrodes or a catheter. Often, 25 failure of surgical ablation [Miller, 1984].
this recording must be done while the abnormal biological	 Several investigators have reported series of studies of
electrical excitation is ongoing. 	 patients selected for having one predominant morphology of
Radio frequency catheter ablation procedures have evolved	 ventricular tachycardia ("clinical ventricular tachycardia")
in recent years to become an established treatment for 	 who were treated with radio frequency catheter ablation [Mo-
patients with a variety of supraventricular [Lee, 1991; Lang- 3o rady, 1993; Kim, 1994]. It is likely that this group of patients
berg, 1993] and ventricular arrhythmias [Stevenson, 1997; 	 represents less than 10% of the total population of patients
Stevenson, 1998]. However, in contrast to supraventricular 	 with ventricular tachycardia [Kim, 1994]. The patient must
tachycardia ablation, which is highly successful because the 	 remain hemodynamically stable while the arrhythmia is
atrio-ventricular node anatomy is known, ventricular tachy- 	 induced and maintained during mapping. The mapping pro-
cardia ablation remains difficult because the site of origin of 35 cedure may take many hours during which the arrhythmia
the arrhythmia could be anywhere in the ventricles. 	 must be maintained. Thus, currently, radio frequency catheter
Sustained ventricular tachycardia is often a difficult 	 ablation is generally limited to "slow" ventricular tachycardia
arrhythmia to manage. One of the most common indications 	 (about 130 bpm) which is most likely to be hemodynamically
for radio frequency catheter ablation of ventricular tachycar- 	 stable.
dia is arrhythmia refractory to drug therapy that results in 40	 Ablation directed towards the "clinical tachycardia" that
frequent discharges from an implantable cardioverter-	 did not target other inducible ventricular tachycardiac suc-
defibrillator. Radio frequency ablation is also indicated when 	 cessfully abolished the "clinical ventricular tachycardia" in
the ventricular tachycardia is too slow to be detected by the	 71% to 76% cases. However, during follow-up up to 31% of
implantable cardioverter-defibrillator or is incessant [Strick- 	 those patients with successful ablation of the "clinical ven-
berger, 1997]. 	 45 tricular tachycardia" had arrhythmic recurrences, some of
Selection of the appropriate target sites for ablation is 	 which were due to different ventricular tachycardia mor-
usually based on a combination of anatomical and electrical 	 phologies from that initially targeted for ablation.
criteria. The ability of the physician to deliver radio-fre- 	 Furthermore, there are several difficulties in selecting a
quency energy through a catheter at the reentry site is 	 dominant, "clinical ventricular tachycardia" for ablation.
restricted by the limitations of the current technology that is 50 Often it is not possible to determine which ventricular tachy-
employed to guide the catheter to the appropriate ablation	 cardia is in fact the one that has occurred spontaneously. In
site. The principal limitation of the radio frequency ablation 	 most cases, only a limited recording of one or a few ECG
technique is the determination of the correct site for delivery	 leads may be available. In patients with implantable defibril-
of the radio frequency energy. Conventionally, this determi- 	 lators ventricular tachycardia is typically terminated by the
nation is achieved by painstaking mapping of the electrical 55 device before an ECG is obtained. Even if one ventricular
activity on the inner surface of the heart from electrodes on	 tachycardia is identified as predominant, other ventricular
the catheter. Often, this recording must be done while the 	 tachycardiac that are inducible may subsequently occur spon-
arrhythmia is ongoing. This is a major problem, especially for 	 taneously. An alternative approach is not to consider the num-
those arrhythmias which compromise hemodynamic func- 	 ber of ventricular tachycardia morphologies in determining
tion of the patient. Many arrhythmias for this reason are not 60 eligibility for catheter ablation but rather to attempt ablation
presently amenable to radio frequency ablation treatment. 	 of all inducible ventricular tachycardiac that are sufficiently
The acute lesion created by radio frequency current con- 	 tolerated to allow mapping [Stevenson, 1998b; Stevenson,
sists of a central zone of coagulation necrosis surrounded by 	 1997]. However, this approach requires that the patient be
a zone of hemorrhage and inflammation. Arrhythmias may	 hemodynamically stable during the ventricular tachycardia
recur if the target tissue is in the border zone of a lesion 65 mapping procedure.
instead of in the central area of necrosis. If the inflammation 	 The use of fluoroscopy (digital bi-plane x-ray) for the
resolves without residual necrosis, arrhythmias may recur 	 guidance of the ablation catheter for the delivery of the cura-
US 7,792,563 B2
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tive radio frequency energy is common to clinical catheter	 One of the co-inventors of the present application is a co-
ablation strategies. However, the use of fluoroscopy for these 	 inventor of these two patents. The concept of considering the
purposes may be problematic for the following reasons: (1) It	 heart as a single dipole generator originated with Einthoven
may not be possible to accurately associate intracardiac elec- 	 [Einthoven, 1912], and its mathematical basis was estab-
trograms with their precise location within the heart; (2) The 5 lished by Gabor and Nelson [Gabor, 1954]. Several investi-
endocardial surface is not visible using fluoroscopy, and the 	 gators [Mirvis, 1981; Gulrajani, 1984], [Tsunakawa, 1987]
target sites can only be approximated by their relationship 	 have studied the cardiac dipole in clinical practice and
with nearby structures such as ribs and blood vessels as well 	 attempted to determine the dipolar nature of the ECG. The
as the position of other catheters; (3) Due to the limitations of 	 advantages of the use of the equivalent cardiac dipole are: (1)
two-dimensional fluoroscopy, navigation is frequently inex- io It permits quantification of source strength in biophysical
act, time consuming, and requires multiple views to estimate 	 terms that are independent of volume conductor size (classic
the three-dimensional location of the catheter; (4) It may not 	 electrocardiography), and (2) The active equivalent source
be possible to accurately return the catheter precisely to a 	 can be localized and assigned a location, something that
previously mapped site; (5) It is desirable to minimize expo- 	 cannot be done using classical electrocardiography.
sure of the patient and medical personnel to radiation; and (6) 15	 For many arrhythmias, the electrical activity within the
Most importantly, fluoroscopy cannot identify the site of ori- 	 heart is highly localized for a portion of the cardiac cycle.
gin of an arrhythmia and thus cannot be used to specifically 	 During the remainder of the cardiac cycle the electrical activ-
direct a catheter to that site. 	 ity may become more diffuse as the waves of electrical activ-
Electro -anatomic mapping systems (e.g., Carto, Biosense,	 ity spread. It is not possible to construct the three-dimensional
Marlton, N.7.) provide an electro -anatomical map of the 20 distribution of cardiac electrical sources from a two-dimen-
heart. This method of nonfluoroscopic catheter mapping is 	 sional distribution of ECG signals obtained on the body sur-
based on an activation sequence to track and localize the tip of
	
face. However, if it is known that a source is localized, then
the mapping catheter by magnetic localization in conjunction 	 this localized source can be approximated as a single equiva-
with electrical activity recorded by the catheter. This 	 lent moving dipole (SEMD), for which one can compute the
approach has been used in ventricular tachycardia [Nade- 25 dipole parameters (i.e., location and moments) by processing
manee, 1998; Stevenson, 1998], atrial flutter [Shah, 1997; 	 electrocardiographic signals acquired from recording elec-
Nakagawa, 1998], and atrial tachycardia ablation [Natale, 	 trodes placed on the body surface or in the body.
1998; Kottkamp, 1997] . The ability to localize in space the tip 	 As described in U.S. Pat. Nos. 6,308,093 and 6,370,412,
of the catheter while simultaneously measuring the electrical
	
fitting the dipole parameters to body surface ECG signals
activity may facilitate the mapping process. However, this 30 provides a solution for the dipole location as well as for its
technique fundamentally has the limitation that it involves	 strength and orientation (referred to herein as the "Inverse
sequentially sampling endocardial sites. The mapping pro- 	 Dipole Method"). The location of the dipole at the time epoch
cess is prolonged while the patients must be maintained in 	 when the electrical activity is confined to the vicinity of the
ventricular tachycardia. Also, the localization is limited to the 	 site of origin of an arrhythmia should coincide with the site of
endocardial surface and thus sites of origin within the myo-  35 origin of the arrhythmia. In contrast to standard mapping
cardium cannot be accurately localized. 	 techniques, the inverse solution can be computed from only a
The basket catheter technique employs a non-contact 	 few beats of the arrhythmia, thereby eliminating the need for
64-electrode basket catheter (Endocardial Solutions Inc., St. 	 prolonged maintenance of the arrhythmia during the local-
Paul, Minn.) placed inside the heart to electrically map the 	 ization process.
heart. In the first part of this procedure high frequency current 40	 In previous methods [Armoundas, 1999; Armoundas,
pulses are applied to a standard catheter used in an ablation 	 2001; Armoundas, 2003] after the site of origin of the arrhyth-
procedure. The tip of this catheter is dragged over the	 mia is localized, one or more electrodes at the ablation cath-
endocardial surface, and a basket catheter is used to locate the 	 eter tip are used to deliver low-amplitude (sub-threshold)
tip of the ablation catheter and thus to trace and reconstruct 	 bipolar current pulses, and the resulting signals are recorded
the endocardial surface of the ventricular chamber. Then the 45 and processed to locate the position of the catheter tip dipole
chamber geometry, the known locations of the basket cath- 	 using the same Inverse Dipole Method. The catheter tip is
eter, and the non-contact potential at each electrode on the 	 guided towards the site of origin of the arrhythmia using the
basket catheter are combined in solving Laplace's equation,	 relative calculated locations of the respective dipoles. When
and electrograms on the endocardial surface are computed. 	 the catheter tip dipole and arrhythmic site dipole are calcu-
This technique has been used in mapping atrial and ventricu-  50 lated to have nearly identical locations, the location of the
lar arrhythmias [Schilling, 1998; Gomick, 1999]. One of the 	 actual catheter tip should also nearly coincide with the site of
drawbacks of this methodology is that the ventricular geom- 	 origin of the arrhythmia. Ablative energy is then delivered.
etry is not fixed but varies during the cardiac cycle. In addi- 	 This method of source localization and catheter guidance
tion, the relative movement between the constantly contract-	 shall be referred to herein as the "Inverse Dipole Method".
ing heart and the electrodes affects the mapping. While the 55	 When the rate of the ventricular tachycardia is low, the
inter-electrode distances on each sidearm of the basket cath- 	 electrical activity from the previous cardiac cycle is no longer
eter are fixed, the distances between the actual recording sites 	 present when the next cardiac cycle begins. On the other hand,
on the endocardium decrease during systole. This leads to 	 if the ventricular tachycardia is fast, electrical activity from
relative movement between the recording electrode and the 	 the previous cycle, now for the most part remote from the site
tissue, significantly limiting the accuracy of the mapping 60 of origin of the arrhythmia, is still present when the next wave
method. Also, the localization is limited to the endocardial 	 of depolarization emerges from that site. The bioelectric
surface, and thus sites of origin within the myocardium can- 	 source dipole is computed from the body surface potentials
not be accurately localized. 	 which in turn reflect a summation of all on-going electrical
U.S. Pat. Nos. 6,308,093 and 6,370,412, the contents of 	 activity in the heart. At the start of the QRS complex during
which are incorporated herein by reference, present a method 65 fast ventricular tachycardia the bioelectrical source dipole
in which a single equivalent moving dipole (SEMD) model 	 will be a summation of both the remote electrical activity
can be used to localize an electrical source within the body. 	 associated with the previous cardiac cycle and the localized
US 7,792,563 B2
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activity newly emerging from the site of origin of the arrhyth-
mia. Consequently, the location of the bioelectric source
dipole will no longer correspond to the location of the site of
origin of the arrhythmia. Therefore, even if the catheter tip
and site of origin of the arrhythmia are in reality superposed, 5
the previously described method will identify their locations
as being different. It is clear that the method described previ-
ously for localizing the arrhythmic site dipole will work only
in the context of slow ventricular tachycardia.
What is needed is a means of efficiently directing the tip of 10
a catheter to the site of origin of both slow and fast arrhyth-
mias to allow the Inverse Dipole Method to be used in all
contexts.
SUMMARY OF THE INVENTION	 15
According to a first aspect, the method of the invention for
locating the site of origin of an arrhythmia includes applying
a multiplicity of recording electrodes to the body. Electrical
activity from the recording electrodes is analyzed to identify 20
the location of the site of origin of the arrhythmia. One or
more stimulating electrodes is introduced into the body and
the heart is stimulated with supra-threshold stimuli through
the one or more stimulating electrodes. The electrical activity
from the recording electrodes is processed to identify the 25
locations of the one or more stimulating electrodes in relation
to the location of the site of origin of the arrhythmia. In a
preferred embodiment, radio frequency energy is delivered to
the location of the site of origin of the arrhythmia to ablate the
site. The arrhythmia may be initiated by electrical stimulation 30
of the heart. The analyzing step may be preformed at a mul-
tiplicity of time epochs during the cardiac cycle and may
involve computing the location of at least one equivalent
moving dipole.
The analyzing step, in one embodiment, involves the appli- 35
cation of a set of criteria to the analysis of electrical activity at
the multiplicity of time epochs in order to determine the site
of origin of the arrhythmia. The criteria may measure the
degree of correlation of direction of movement between suc-
cessive dipoles, and/or the magnitude of the dipole and/or the 40
dipole moment and/or the degree of fit of the dipole model to
the measured data and/or other dipole parameters. The loca-
tion of the site of origin of the arrhythmia may be displayed on
a display serving as a graphical user interface.
In another aspect, the invention is a system for locating the 45
site of origin of an arrhythmia including a multiplicity of
recording electrodes adapted for attachment to a body. Signal
processing equipment analyses the electrical activity from the
recording electrodes to identify the location of the site of
origin of the arrhythmia. Stimulating electrodes are provided
for introduction into the body for stimulating the heart with
supra-threshold stimuli. A computer system processes the
electrical activity from the recording electrodes to identify the
locations of the one or more stimulating electrodes in relation
to the location of the site of origin of the arrhythmia. In a
preferred embodiment of this aspect of the invention the
system includes circuitry for delivering radio frequency
energy to ablate the site of origin of the arrhythmia.
In preferred embodiments the methods of the present
invention involve applying a multiplicity of recording elec-
trodes to the body, analyzing the electrical activity from the
recording electrodes to identify the location of the site of
origin of the arrhythmia, introducing one or more stimulating
electrodes into the body, stimulating the heart with supra-
threshold stimuli through the one or more stimulating elec-
trodes, and processing the electrical activity from the record-
ing electrodes to identify the locations of the one or more
6
stimulating electrodes this latter electrical activity reflects
the signals emanating from both the stimulating electrode(s)
and from the heart due to the stimuli from the stimulating
electrode(s).
In a preferred embodiment, the arrhythmia is initiated by
means of electrical stimulation of the heart. The analyzing
step is used to identify the location of the site of origin of the
arrhythmia by analyzing the electrical activity at a multiplic-
ity of time epochs during the cardiac cycle. In a particularly
preferred embodiment, the analyzing step involves comput-
ing the location of at least one equivalent moving dipole from
the acquired signals. A set of criteria may be applied to the
analyses of electrical activity at a multiplicity of time epochs
in order to determine the site of origin of the arrhythmia. In a
preferred embodiment, these criteria involve measures of the
degree of correlation of direction of movement between suc-
cessive dipoles, and/or the magnitude of the dipole, and/or the
dipole moment, and/or the degree of `fit' of the dipole model
to the measured data, and/or other dipole parameters. In
another preferred embodiment, the location of the site of
origin of the arrhythmia is then displayed on a graphical user
interface.
In a preferred embodiment, the stimulating electrodes are
used to stimulate the heart. In a particularly preferred embodi-
ment the stimulating step involves pacing the heart at approxi-
mately the same rate as the rate of the arrhythmia. The loca-
tions of the one or more stimulating electrodes are identified
by analyzing the electrical activity at a multiplicity of time
epochs during the cardiac cycle. In a preferred embodiment,
this involves computing the location of at least one equivalent
moving dipole. A set of criteria may be applied to the analyses
of electrical activity at a multiplicity of time epochs in order
to determine the locations of the one or more stimulating
electrodes. In a preferred embodiment, these criteria involve
measures of the degree of correlation of direction of move-
ment between successive dipoles, and/or the magnitude of the
dipole, and/or the dipole moment, and/or the time elapsed
since stimulation of the cardiac tissue, and/or the degree of
`fit' of the dipole model to the measured data, and/or other
dipole parameters. In another preferred embodiment, the
locations of the one or more stimulating electrodes are then
displayed on a graphical user interface.
In a particularly preferred embodiment, the stimulating
electrodes are advanced towards the site of origin of the
arrhythmia. During this process, the stimulating, processing
and advancing steps are performed iteratively. In another
preferred embodiment, radio-frequency energy is then deliv-
ered to ablate the site of origin of the arrhythmia.
50	 BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 is a flow chart of a preferred embodiment of the
method for localizing a site of origin of the arrhythmia within
the body.
55 FIG. 2 is a schematic diagram of an apparatus for localizing
a site of origin of an arrhythmia, guiding the delivery of
ablative therapy, and delivering ablative therapy to the site of
origin of the arrhythmia.
60	 DESCRIPTION OF THE PREFERRED
EMBODIMENTS
Previous patents (U.S. Pat. Nos. 6,308,093 and 6,370,412
discussed above) have described a method by which the elec-
65 trical source of low-frequency electrical activity (such as a
slow ventricular tachycardia) within the body can be local-
ized and ablated. However, the ablation catheter tip cannot be
US 7,792,563 B2
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accurately guided in the manner described in previous patents
in the presence of a rapid arrhythmia (such as in cases of fast
ventricular tachycardia, >240 beats per minute).
In previous methods, low-amplitude sub-threshold bipolar
current pulses are delivered from an electrode at the tip of the s
catheter. The signals at the body surface result solely from the
weak electrical fields set up in the body by the bipolar pulses.
These surface signals are fitted with a moving dipole model to
determine the relative location of the stimulating electrode
within a given short time epoch. Thereafter, the processes of io
delivering electrical energy and determining the relative loca-
tion of the stimulating electrode are repeated until the loca-
tions of the stimulating electrode tip and the site of origin of
the arrhythmia are nearly identical. This method is only suit-
able for conditions of slow ventricular tachycardia. Slow 15
ventricular tachycardia is characterized by a completion of
the previous ventricular excitation and repolarization before
the next ventricular excitation begins. It is evidenced by the
presence of an isoelectric period between the T wave from the
previous cardiac cycle and the QRS from the current cardiac 20
cycle.
However, in cases of fast ventricular tachycardia, electrical
activity from the previous cycle, now for the most part remote
from the site of origin of the arrhythmia, is still present when
the next wave of depolarization emerges from that site. The 25
bioelectric source dipole is computed from the body surface
potentials which in turn reflect a summation of all on-going
electrical activity in the heart. At the start of the QRS complex
during fast ventricular tachycardia the bioelectrical source
dipole will be a summation of both the remote electrical 30
activity associated with the previous cardiac cycle and the
localized activity newly emerging from the site of origin of
the arrhythmia. Consequently, the location of the bioelectric
source dipole will no longer correspond to the location of the
site of origin of the arrhythmia. Therefore, even if the catheter 35
tip and site of origin of the arrhythmia are in reality super-
posed, the previously described method will identify their
locations as being different. As a result, the method proposed
in previous patents for matching an ablation catheter to the
site of origin of the arrhythmia is suboptimal in the context of 40
fast ventricular tachycardia. This problem is solved by our
current innovation.
FIG. 1 shows a flowchart of the method according to the
present invention for localizing the site of origin of an
arrhythmia within the body. The method involves applying a 45
multiplicity of recording electrodes to the body. The signals
from the recording electrodes are analyzed to identify the
location of the site of origin of the arrhythmia. One or more
stimulating electrodes are introduced into the body and are
used to stimulate the heart with supra-threshold stimuli. The so
electrical activity recorded by the recording electrodes is
processed to identify the locations of the one or more stimu-
lating electrodes this latter electrical activity reflects the
signals emanating from both the stimulating electrode(s) and
from the heart due to the stimuli from the stimulating elec- 55
trode(s).
The stimulating electrodes may be used to pace the heart
with supra-threshold stimuli at the same rate as the ventricular
tachycardia, with at least two pacing stimuli applied. If the
pacing and ventricular tachycardia rates are the same, and the 60
stimulating electrode locations) and site of origin of the
arrhythmia are nearly superposed, the locations deduced
from the analysis of the electrical signals from the recording
electrodes of the site of origin of the arrhythmia and of the
stimulating electrode(s) will also be approximately super- 65
posed. This is so because in both cases the locations are
deduced from the electrical activity of the heart muscle which
8
is stimulated in the same pattern whether originating from a
bioelectrical source in the site of origin of the arrhythmia or
from the stimulating electrode(s). Therefore, this method
may be used to locate the site of origin of the arrhythmia by
determining when the stimulating electrode(s) are approxi-
mately superposed on it.
In preferred embodiments of the invention, the arrhythmia
is initiated by means of electrical stimulation of the heart and
the resulting electrical activity is analyzed at a multiplicity of
time epochs during the cardiac cycle. In a preferred embodi-
ment, this analysis involves computing the location of an
equivalent moving dipole for at least one time epoch. Com-
puting the location of more than one equivalent moving
dipole allows one to identify the site of origin of the arrhyth-
mia by examining not only the initial electrical activity in the
cardiac cycle but also the path the equivalent dipole follows
after electrical activity leaves the site of origin of the arrhyth-
mia. In a preferred embodiment, in order to determine the site
of origin of the arrhythmia a set of criteria is applied to the
analyses of electrical activity at the multiplicity of time
epochs. These criteria may include measures of the dipole
magnitude, dipole moment, the degree of `fit' of the dipole
model to the measured data, and/or the degree of correlation
of direction of movement between successive dipoles. This
latter criterion searches for the time epoch at which electrical
activity begins moving away from the site of origin of the
arrhythmia. At this time instant, we would expect movement
between successive dipoles to become highly correlated.
Once the site of origin of the arrhythmia has been identi-
fied, in another preferred embodiment its location is dis-
played on a graphical user interface. If an equivalent moving
dipole model was used in the analysis of electrical activity,
features such as dipole size, strength, model fit and/or uncer-
tainty in the dipole location may be simultaneously displayed
on the interface.
As shown in FIG. 1, one or more catheters bearing stimu-
lating electrodes at their tips are introduced into the body. In
a preferred embodiment of the present invention, the heart is
paced using supra-threshold pulses delivered by the at least
one stimulating electrode while the heart is in sinus rhythm.
The stimulating electrode(s) are close to or in contact with the
cardiac tissue. Two signals are subsequently recorded at the
torso surface: those due to the weak electric field created
momentarily by the stimulating currents themselves, and
those due to the regenerating electrical activity of the cardiac
tissue activated by the supra-threshold stimulation. In a pre-
ferred embodiment, the locations of the one or more stimu-
lating electrodes are identified by analyzing the electrical
activity at a multiplicity of time epochs during the cardiac
cycle. In another preferred embodiment, this involves com-
putation of the location of at least one equivalent moving
dipole. Computing the locations of more than one equivalent
moving dipole allows one to identify not only the location of
the stimulating electrode but also the path the equivalent
dipole follows after the supra-threshold stimulus.
In a preferred embodiment, a set of criteria is applied to the
analyses of signals at a multiplicity of time epochs to find the
locations) of the one or more stimulating electrodes. These
criteria may include measures of the dipole magnitude, the
dipole moment, the degree of `fit' of the dipole model to the
measured signals, the time elapsed since stimulation of the
cardiac tissue, and/or the degree of correlation of direction of
movement between successive dipoles. This latter criterion
searches for the time epoch at which electrical activity begins
moving through the cardiac tissue away from the site of
US 7,792,563 B2
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application of the supra-threshold pulses. At this time instant,
we would expect movement between successive dipoles to
become highly correlated.
The stimulating electrodes may be used to pace the heart
with supra-threshold stimuli at the same rate as the ventricular 5
tachycardia, with at least two pacing stimuli applied at each
location of the stimulating electrode(s). If the pacing and
ventricular tachycardia rates are the same, and the stimulating
electrode location and site of origin of the arrhythmia are
nearly superposed, their two corresponding equivalent dipole io
locations will also be nearly superposed. This will be the case
even though neither dipole may reflect the actual location of
its electric source. By the same token, if their equivalent
dipole locations are nearly identical we may be sure that the
actual locations of the stimulating electrode(s) and site of 15
origin of the arrhythmia are nearly identical. Therefore, this
method may be used to locate the site of origin of the arrhyth-
mia by determining when the stimulating electrode(s) are
approximately superposed on it.
In one preferred embodiment, the locations of the one or 20
more stimulating electrodes are displayed on a graphical user
interface. In another preferred embodiment, the stimulating
electrode(s) are advanced towards the site of origin of the
arrhythmia. If the location of the site of origin of the arrhyth-
mia is displayed on the graphical user interface along with the 25
locations) of the stimulating electrode(s), the interface will
aid in the guidance of the stimulating electrode towards the
site of origin of the arrhythmia.
In a particularly preferred embodiment, the processes of
stimulating the cardiac tissue with supra-threshold energy, 30
processing the signals emanating from the at least one stimu-
lating electrode and activated cardiac tissue, and positioning
the at least one stimulating electrode are performed itera-
tively. The process may be terminated when the site of origin
of the arrhythmia and the stimulating electrode(s) are nearly 35
superposed. Near-superposition may be indicated by near-
alignment of the locations corresponding to the site of origin
of the arrhythmia and the stimulating electrode(s). It may also
be indicated by the similarity of the paths followed by the
equivalent moving dipole over multiple time epochs. In a 40
preferred embodiment of this invention, radio-frequency
energy is then delivered to ablate the site of origin of the
arrhythmia.
This method may also be applied in the localization of the
site of origin of a slow arrhythmia, when there is no remote 45
electrical activity present when the next depolarization
begins. Therefore it may be used to guide ablative therapy in
the context of an arrhythmia regardless of its rate.
FIG. 2 shows a preferred embodiment of the system for
localizing the site of origin of the arrhythmia, guiding the 50
delivery of ablative energy, and delivering ablative energy to
the vicinity of the site of origin of the arrhythmia. A multi-
plicity of recording electrodes 11 are placed on the body
surface of a subject 10 such that the heart 6 may be viewed
from the anterior, left lateral, right lateral, and posterior chest. 55
Each electrode 11 position is provided by the operator to
the analysis software. Signals from the recording electrodes
11 are carried in a multi-lead cable 12 through an isolation
amplifier 13 to an amplifier bank 14 with adjustable gain and
frequency response. A computer 15 equipped with a multi- 60
plexor and an analog to digital conversion card digitizes and
processes the signals emanating from the site of origin of the
arrhythmia and the signals arising due to pacing by a stimu-
lating electrode 16 placed within the heart 6. As described in
detail above, in a preferred embodiment of the invention the 65
processing step utilizes a single equivalent moving dipole
(SEND) model to localize both the site of origin of the
10
arrhythmia and the stimulating electrode 16 at a series of time
epochs. The computer 15 also creates an electronic represen-
tation of the signals acquired from each electrode 11, stores
the signals, and displays the signals on a display 17. To
inspect the signals the operator may display them off-line
from storage at a rate slower than real time. The position,
magnitude, and orientation of the SEMD attributed to cardiac
electrical activity at each time epoch are displayed in a three-
dimensional view of the heart 6. The uncertainty in the posi-
tion of the SEMD and the goodness-of-fit value of the esti-
mation of the SEMD parameters may also be displayed for
each time epoch.
An ablation catheter 18 with its at least one stimulating
electrode 16 is placed in the heart 6 of the subject. The
catheter 18 is connected through a high-voltage isolation
stage 19 that serves as an automatic switch (the switch auto-
matically turns off the signal generator circuit after sensing
the radio frequency source) to a signal generator 20, which is
controlled by the computer 15 and can generate a supra-
threshold signal (of sufficient magnitude to pace the heart).
The position, magnitude, and orientation of the dipole attrib-
uted to the tip of the catheter are displayed for each time
epoch. The uncertainty in the position of the dipole attributed
to the tip of the catheter and the goodness-of-fit value of the
estimation of the dipole parameters attributed to the tip of the
catheter 18 are also displayed for each time epoch. A radio
frequency source 21 controlled by the operator is also
attached to the ablation catheter 18. After localization of the
source of abnormal electrical activity (i.e., the site of origin of
the arrhythmia) and positioning of the tip of the catheter 18 at
the source of abnormal electrical activity as described above,
the catheter 18 is used to deliver ablative radio frequency
energy to the vicinity of the site of origin of the arrhythmia.
The present invention thus provides methods and apparatus
for localizing the site of origin of an arrhythmia. The inven-
tion further provides methods and apparatus for delivering
ablative electrical energy in the vicinity of the site of origin of
the arrhythmia. The present invention is particularly appli-
cable in the context of fast ventricular arrhythmias, although
it may be used in any context in which an ablation catheter
must be guided to a focused source of electrical activity.
Cardiac arrhythmias are frequently treated by delivering
electrical energy to the site of origin of the arrhythmia in an
effort to ablate the site. To effectively perform this procedure,
accurate localization of both the site of origin of the arrhyth-
mia and the energy delivery device (e.g., the tip of a catheter)
are necessary. As used herein, the term "localization" refers to
determining either an absolute or a relative location. The
present invention thus provides techniques for accurately per-
forming such localization. The minimally invasive and fast
aspects of certain embodiments of the invention, as disclosed
herein, are particularly important.
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It is recognized that modifications and variations of the
present invention will occur to those skilled in the art, and it is
intended that all such modifications and variations be
included within the scope of the appended claims.
What is claimed is:
1. Method for locating a site of origin of an arrhythmia,
comprising:
applying a multiplicity of recording electrodes to a body;
analyzing electrical activity from the recording electrodes
to identify a location of the site of origin of the arrhyth-
mia;
introducing one or more stimulating electrodes into the
body;
stimulating a heart with supra-threshold stimuli through
the one or more stimulating electrodes; and
processing the electrical activity from the recording elec-
trodes to identify locations of the one or more stimulat-
ing electrodes in relation to the location of the site of
origin of the arrhythmia.
2. The method of claim 1 further comprising initiation of
the arrhythmia by electrical stimulation of the heart.
3. The method of claim 1 wherein the analyzing step is used
to identify the location of the site of origin of the arrhythmia
by analyzing the electrical activity at a multiplicity of time
epochs during a cardiac cycle.
4. The method of claim 1 wherein the analyzing step
includes computing a location of at least one equivalent mov-
ing dipole.
5. The method of claim 3 wherein the analyzing step
includes application of a set of criteria to the analyses of
electrical activity at the multiplicity of time epochs in order to
determine the site of origin of the arrhythmia.
6. The method of claim 5 wherein the criteria include
measures of a degree of correlation of direction of movement
14
between successive dipoles, and/or a magnitude of a dipole,
and/or a dipole moment, and/or a degree of `fit' of a dipole
model to measured data, and/or other dipole parameters.
7. The method of claim 1 wherein the location of the site of
5 origin of the arrhythmia is displayed on a graphical user
interface.
8. The method of claim 1 wherein the processing step is
used to identify the locations of the one or more stimulating
electrodes by analyzing the electrical activity at a multiplicity
io of time epochs during a cardiac cycle.
9. The method of claim 1 wherein the stimulating step
includes pacing the heart at approximately the same rate as
the rate of the arrhythmia.
10. The method of claim 1 wherein the processing step
15 includes computing a location of at least one equivalent mov-
ing dipole.
11. The method of claim 8 wherein the processing step
includes application of a set of criteria to the analyses of
electrical activity at the multiplicity of time epochs in order to
20 determine the locations of the one or more stimulating elec-
trodes.
12. The method of claim 11 wherein the criteria involve
measures of a degree of correlation of direction of movement
between successive dipoles, and/or a magnitude of a dipole,
25 and/or a dipole moment, and/or a time elapsed since stimu-
lation of the cardiac tissue, and/or a degree of `fit' of a dipole
model to the measured data, and/or other dipole parameters.
13. The method of claim 1 wherein the locations of the one
or more stimulating electrodes are displayed on a graphical
so user interface.
14. The method of claim 1 further comprising advancing of
the one or more stimulating electrodes towards the site of
origin of the arrhythmia.
15. The method of claim 14 wherein the stimulating, pro-
s y cessing and advancing steps are performed iteratively.
16. The method of claim 1 further comprising delivering
radio-frequency energy to ablate the site of origin of the
arrhythmia.
